V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20050520 | 20086463 | 1.71 | 128 | Palliative (P) | 2018-11-14 | 2018-12-12 | Docetaxel | 02 | Y | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101095839 |
| 20050542 | 20086464 | 1.62 | 126.1 | Palliative (P) | 2021-08-04 | 2021-08-06 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | Y | CISPLATIN + FLUOROURACIL + RT | 100447499 |
| 20050662 | 20086465 | 1.67 | 80 | Palliative (P) | 2020-06-30 | 2020-06-30 | Hydroxycarbamide | 02 | Y | ECARBOX | 101609131 |
| 20050716 | 20086466 | 1.84 | 60.1 | null | 2018-04-23 | 2018-04-23 | Bevacizumab + Oxaliplatin +MdG | 02 | N | PANITUMUMAB | 100482825 |
| 20050719 | 20086467 | 1.58 | 52.7 | 03 | 2018-01-01 | 2018-01-02 | IBRUTINIB | N | N | NAB-PACLITAXEL | 100665099 |
| 20050739 | 20086468 | 1.69 | 71.5 | Palliative (P) | 2017-11-24 | 2017-12-22 | NIVOLUMAB | 02 | null | ECARBOX | 100883435 |
| 20050773 | 20086470 | 1.82 | 73.4 | Palliative (P) | 2017-04-18 | 2017-04-20 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | RITUXIMAB | 100896343 |
| 20050899 | 20086471 | null | 55 | null | 2017-09-29 | 2017-10-07 | EEF or EOF | 02 | null | CAPECITABINE + STREPTOZOCIN | 101581062 |
| 20050981 | 20086472 | 1.81 | 59.2 | 03 | 2017-04-06 | 2017-04-07 | null | 02 | N | CAPE + OXALIPLATIN + TRASTUZUMAB | 100094268 |
| 20050988 | 20086473 | 1.62 | 58.4 | Adjuvant (A) | null | 2018-11-23 | Fluorouracil + Streptozocin | null | N | ESPAC TRIAL | 100897041 |
| 20051015 | 20086474 | null | 99.7 | 03 | 2017-10-28 | 2017-11-17 | Fluorouracil + Folinic + RT Bossett | 02 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101735953 |
| 20051019 | 20086475 | 1.76 | 77 | 03 | 2018-01-14 | 2018-01-14 | Gemcitabine + Paclitaxel | null | Y | CYTARABINE | 101859993 |
| 20051037 | 20086476 | 1.68 | 108 | 03 | 2020-02-15 | 2020-02-15 | Capecitabine+Cisplatin+Streptozocin | 02 | N | CAPECITABINE + STREPTOZOCIN | 100675911 |
| 20051052 | 20086477 | 1.71 | 50.4 | 03 | 2019-08-29 | 2019-09-21 | ABVD | 02 | N | ARISTOTLE TRIAL | 101437917 |
| 20051068 | 20086478 | 1.7 | 71.8 | 03 | 2018-08-06 | 2018-08-17 | null | 02 | N | CHOP R | 101786281 |
| 20051113 | 20086479 | 1.65 | 69.65 | 03 | 2022-02-09 | 2022-03-11 | PEGINTERFERON ALFA | 02 | N | DOCETAXEL | 100716688 |
| 20051133 | 20086480 | 1.67 | 70 | Adjuvant (A) | 2017-03-14 | 2017-03-28 | IBRUTINIB | N | N | SUNITINIB | 100056620 |
| 20051149 | 20086481 | 1.82 | 75 | Palliative (P) | 2019-11-09 | 2019-12-07 | Docetaxel | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 100637666 |
| 20051201 | 20086482 | 1.58 | 90.9 | Palliative (P) | null | 2019-05-26 | Lenalidomide 25mg (Cycle 1 to 25) | 02 | N | DOXORUBICIN | 101565363 |
| 20051215 | 20086483 | 1.71 | 48.3 | 03 | 2017-07-16 | 2018-07-20 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | N | N | HEP SIOPEL 6 CISPLATIN | 100707335 |
| 20051225 | 20086484 | 1.69 | 71.4 | 03 | 2020-03-10 | 2020-03-14 | ACELARATE Trial | 01 | N | PACLITAXEL | 101367061 |
| 20051228 | 20086485 | 1.65 | 96 | Palliative (P) | 2018-02-14 | 2018-03-16 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | Y | RITUXIMAB | 101387828 |
| 20051242 | 20086486 | 1.65 | 80 | Palliative (P) | 2017-05-31 | 2017-06-17 | CISPLATIN + RT | 02 | N | LENALIDOMIDE | 100826751 |
| 20051277 | 20086487 | 1.54 | 0 | Palliative (P) | 2016-12-24 | 2017-01-08 | PLATO Trials | 02 | Y | PLATO TRIAL | 100266273 |
| 20051345 | 20086488 | 1.84 | 84.1 | Palliative (P) | 2021-06-22 | 2021-06-22 | Fluorouracil + Folinic + RT Bossett | 02 | N | ESPAC TRIAL | 100705320 |
| 20051350 | 20086489 | 1.74 | 59.85 | 03 | 2017-02-27 | 2017-02-27 | CISPLATIN + FLUOROURACIL + RT | 02 | N | PACLITAXEL | 100408747 |
| 20051504 | 20086493 | 1.6 | 76 | Palliative (P) | 2020-05-20 | 2020-05-27 | Radium 223 | 02 | N | DOCETAXEL | 101775546 |
| 20051582 | 20086494 | 1.84 | 69.2 | Palliative (P) | 2018-07-04 | 2018-07-10 | EEF or EOF | 02 | N | CETUXIMAB + IRINOTECAN | 101816335 |
| 20051589 | 20086495 | 1.71 | 92.5 | 03 | 2021-03-25 | 2021-04-13 | GO2 TRIAL | 02 | N | OXALIPLATIN | 100615686 |
| 20051594 | 20086496 | 1.54 | 66.1 | 03 | 2018-12-09 | 2018-12-10 | TAC | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 101223664 |
| 20051607 | 20086497 | 1.79 | 71 | 03 | 2017-03-07 | 2017-09-20 | FEC 100 + TRASTUZUMAB | 02 | null | ESPAC TRIAL | 100167997 |
| 20051618 | 20086498 | null | 61.3 | Adjuvant (A) | 2018-01-26 | 2018-01-27 | SCOPE 2 TRIAL | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100150409 |
| 20051647 | 20086499 | 1.9 | 81.45 | Palliative (P) | 2016-08-27 | 2016-10-24 | Streptozocin + MdG | 02 | Y | EOF | 100703874 |
| 20051654 | 20086500 | 1.68 | 83.9 | Palliative (P) | 2017-11-06 | 2017-12-30 | ESPAC-4 TRIAL | 02 | N | IRINOTECAN | 101687697 |
| 20051655 | 20086501 | 1.76 | 102 | Palliative (P) | 2020-01-26 | 2020-02-09 | ABEMACICLIB + FULVESTRANT | 01 | N | BACILLUS CALMETTE-GUERIN | 100810846 |
| 20051659 | 20086502 | null | null | Palliative (P) | 2017-09-12 | 2017-09-29 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | FOXTROT TRIAL | 101829910 |
| 20051660 | 20086503 | 1.82 | 80.2 | null | null | 2018-03-15 | ACTICCA-1 Trial | 2 | N | PRIMUS 002 TRIAL | 100434023 |
| 20051690 | 20086504 | 1.57 | 92 | 03 | 2016-05-22 | 2016-05-22 | Capital Trial | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101061216 |
| 20051715 | 20086505 | 1.67 | 60.3 | null | 2018-10-19 | 2018-10-27 | BCG Intravesical | 02 | N | PEMBROLIZUMAB | 100273358 |
| 20051792 | 20086507 | 1.68 | 63 | null | 2018-01-10 | 2018-01-10 | STS Rhabdomyosarcoma RMS 2005 IVAVV | null | N | DOCETAXEL | 101558887 |
| 20051818 | 20086508 | 1.88 | 50 | 03 | 2019-11-26 | 2019-12-11 | Rituximab | 02 | N | FCARBOST | 100004454 |
| 20051826 | 20086509 | 1.55 | null | Palliative (P) | 2019-04-29 | 2019-05-14 | GEM-P | 01 | N | YTTRIUM-90 | 101686745 |
| 20051830 | 20086510 | 1.69 | 62.5 | 03 | 2019-08-27 | 2019-08-27 | Bortezomib + Panobinostat | 01 | Y | PLATFORM TRIAL | 100946486 |
| 20051853 | 20086511 | 1.75 | 58.6 | Palliative (P) | null | 2018-03-10 | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 01 | N | PACLITAXEL | 101245485 |
| 20051858 | 20086512 | 1.54 | 46.5 | Palliative (P) | 2017-05-16 | 2017-05-22 | null | 2 | N | AZACITIDINE | 101811196 |
| 20051861 | 20086513 | 1.64 | 49.15 | Palliative (P) | 2017-04-12 | 2017-04-12 | CISPLATIN + RT | null | N | HYDROXYCARBAMIDE | 101572304 |
| 20051923 | 20086514 | 1.66 | 88.85 | null | 2018-11-10 | 2018-11-25 | Capecitabine + Streptozocin | 02 | N | GEMCARBO | 100732713 |
| 20051933 | 20086515 | 1.83 | 71.5 | 03 | 2018-12-26 | 2018-12-26 | Bevacizumab + Oxaliplatin +MdG | 02 | N | HYDROXYCARBAMIDE | 100612850 |
| 20051962 | 20086516 | 1.79 | 65.3 | Palliative (P) | 2019-08-16 | 2019-08-21 | null | 02 | N | PANITUMUMAB | 101681843 |
| 20051976 | 20086517 | 0 | 0 | 03 | 2019-07-23 | 2019-07-31 | CARBOPLATIN + VINORELBINE | 01 | N | CISPLATIN + PEMETREXED | 100613665 |